|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Laskin JJ and Sandler AB: State of the art
in therapy for non-small cell lung cancer. Cancer Invest.
23:427–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferguson MK: Diagnosing and staging of
non-small cell lung cancer. Hematol Oncol Clin North Am.
4:1053–1068. 1990.PubMed/NCBI
|
|
5
|
Del Vescovo V, Grasso M, Barbareschi M and
Denti MA: MicroRNAs as lung cancer biomarkers. World J Clin Oncol.
5:604–620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang T, Thakur A, Chen T, Yang L, Lei G,
Liang Y, Zhang S, Ren H and Chen M: MicroRNA-15a induces cell
apoptosis and inhibits metastasis by targeting BCL2L2 in non-small
cell lung cancer. Tumour Biol. 36:4357–4365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CZ and Lodish HF: MicroRNAs as
regulators of mammalian hematopoiesis. Semin Immunol. 17:155–165.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nature Rev Cancer. 6:857–866. 2006. View Article : Google Scholar
|
|
11
|
Li J, Wang Y, Song Y, Fu Z and Yu W:
miR-27a regulates cisplatin resistance and metastasis by targeting
RKIP in human lung adenocarcinoma cells. Mol Cancer. 13:1932014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A-549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan P, Yin Z, Li X, Wu W and Zhou B:
Meta-analysis of human lung cancer microRNA expression profiling
studies comparing cancer tissues with normal tissues. J Exp Clin
Cancer Res. 31:542012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsuchida A, Ohno S, Wu W, Borjigin N,
Fujita K, Aoki T, Ueda S, Takanashi M and Kuroda M: miR-92 is a key
oncogenic component of the miR-17-92 cluster in colon cancer.
Cancer Sci. 102:2264–2271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Pan JH, Song B, Xiong EQ, Chen ZW,
Zhou ZS and Su YP: Suppression of CX43 expression by miR-20a in the
progression of human prostate cancer. Cancer Biol Ther. 13:890–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang CC, Yang YJ, Li YJ, Chen ST, Lin BR,
Wu TS, Lin SK, Kuo MY and Tan CT: MicroRNA-17/20a functions to
inhibit cell migration and can be used a prognostic marker in oral
squamous cell carcinoma. Oral Oncol. 49:923–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan MQ, Huang CB, Gu Y, Xiao Y, Sheng JX
and Zhong L: Decrease expression of microRNA-20a promotes cancer
cell proliferation and predicts poor survival of hepatocellular
carcinoma. J Exp Clin Cancer Res. 32:212013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia Y, Chen Q, Zhong Z, Xu C, Wu C, Liu B
and Chen Y: Down-regulation of miR-30c promotes the invasion of
non-small cell lung cancer by targeting MTA1. Cell Physiol Biochem.
32:476–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang H, Zhang H, Zhao M, Lv Z, Zhang X,
Qin X, Wang H, Wang S, Su J, Lv X, et al: MiR-138 inhibits tumor
growth through repression of EZH2 in non-small cell lung cancer.
Cell Physiol Biochem. 31:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu N, Zhang C, Bai C, Han YP and Li Q:
MiR-4782-3p inhibited non-small cell lung cancer growth via USP14.
Cell Physiol Biochem. 33:457–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
ELife. 4:102015. View Article : Google Scholar
|
|
24
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and expression.
Nucleic Acids Res. 36:D149–D153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43(Database issue): D146–D152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cho WC: OncomiRs: The discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang Y, Liu C, Yang J, Liu G, Feng F,
Tang J, Hu L, Li L, Jiang F, Chen C, et al: MiR-20a triggers
metastasis of gallbladder carcinoma. J Hepatol. 59:518–527. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou J, Liu R, Luo C, Zhou X, Xia K, Chen
X, Zhou M, Zou Q, Cao P and Cao K: MiR-20a inhibits cutaneous
squamous cell carcinoma metastasis and proliferation by directly
targeting LIMK1. Cancer Biol Ther. 15:1340–1349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang G, Liu X, Wang W, Cai Y, Li S, Chen
Q, Liao M, Zhang M, Zeng G, Zhou B, et al: Down-regulation of
miR-20a-5p triggers cell apoptosis to facilitate mycobacterial
clearance through targeting JNK2 in human macrophages. Cell Cycle.
15:2527–2538. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Joseph LJ, le Beau MM, Jamieson GA Jr,
Acharya S, Shows TB, Rowley JD and Sukhatme VP: Molecular cloning,
sequencing and mapping of EGR2, a human early growth response gene
encoding a protein with ‘zinc-binding finger’ structure. Proc Natl
Acad Sci USA. 85:pp. 7164–7168. 1988; View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dzialo-Hatton R, Milbrandt J, Hockett RD
Jr and Weaver CT: Differential expression of Fas ligand in Th1 and
Th2 cells is regulated by early growth response gene and NF-AT
family members. J Immunol. 166:4534–4542. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Unoki M and Nakamura Y: Growth-suppressive
effects of BPOZ and EGR2, two genes involved in the PTEN signaling
pathway. Oncogene. 20:4457–4465. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: miR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
